Trial intelligence / Profile preview

Elcatonin for osteoporosis with lumbar spinal canal stenosis

ChiCTR-IPR-14005501Phase 4Recruiting

Sponsor
Beijing Friendship Hospital
Start
Oct 2014
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in osteoporosis and lumbar spinal stenosis (LSS) comparing Elcatonin with Placebo (2 arms). Primary endpoints: Walking distance and VAS score. Started Oct 2014; status: recruiting.

02

Drugs

elcatonin
03

Conditions

osteoporosislumbar spinal stenosis (LSS)

Beyond the preview

Go deeper on ChiCTR-IPR-14005501.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-14005501.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call